EcoR1 Capital’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,117,400
| Closed | -$18.7M | – | 61 |
|
|
2024
Q1 | $18.7M | Hold |
6,117,400
| – | – | 0.47% | 38 |
|
|
2023
Q4 | $19.7M | Hold |
6,117,400
| – | – | 0.51% | 31 |
|
|
2023
Q3 | $23.5M | Hold |
6,117,400
| – | – | 0.79% | 24 |
|
|
2023
Q2 | $20.1M | Hold |
6,117,400
| – | – | 0.49% | 27 |
|
|
2023
Q1 | $15.8M | Hold |
6,117,400
| – | – | 0.51% | 31 |
|
|
2022
Q4 | $11.4M | Hold |
6,117,400
| – | – | 0.35% | 35 |
|
|
2022
Q3 | $11.3M | Hold |
6,117,400
| – | – | 0.33% | 36 |
|
|
2022
Q2 | $13.2M | Hold |
6,117,400
| – | – | 0.45% | 35 |
|
|
2022
Q1 | $19.2M | Buy |
6,117,400
+35,200
| +0.6% | +$111K | 0.6% | 32 |
|
|
2021
Q4 | $19.5M | Hold |
6,082,200
| – | – | 0.62% | 27 |
|
|
2021
Q3 | $20.4M | Hold |
6,082,200
| – | – | 0.71% | 25 |
|
|
2021
Q2 | $23.8M | Hold |
6,082,200
| – | – | 0.89% | 26 |
|
|
2021
Q1 | $24.5M | Buy |
+6,082,200
| New | +$24.5M | 1.08% | 23 |
|